Abiopharma

New Form 10-Q - HEALTHSTREAM INC Filed: 2025-05-09 AccNo: 0001437749-25-015812 Size: 3 MB

New Form 4 - NATIONAL HEALTHCARE CORP Filed: 2025-05-09 AccNo: 0001437749-25-015814 Size: 10 KB

New Form 6-K for Altamira Therapeutics

New Form 4 - NATIONAL HEALTHCARE CORP Filed: 2025-05-09 AccNo: 0001437749-25-015808 Size: 11 KB

New Form DEFA14A - Kiniksa Pharmaceuticals International, plc Filed: 2025-05-09 AccNo: 0001104659-25-046775 Size: 1 MB

New Form 10-Q - Progyny, Inc. Filed: 2025-05-09 AccNo: 0001551306-25-000103 Size: 5 MB

New Form F-3 - Adagene Inc. Filed: 2025-05-09 AccNo: 0001104659-25-046772 Size: 1 MB

Olema Oncology to Participate in Upcoming Investor Conferences

New Form 424B5 - Can-Fite BioPharma Ltd. Filed: 2025-05-09 AccNo: 0001213900-25-041559 Size: 27 KB

New Form 10-Q - GYRE THERAPEUTICS, INC. Filed: 2025-05-09 AccNo: 0000950170-25-068089 Size: 12 MB

New Form 10-Q - ORAGENICS INC Filed: 2025-05-09 AccNo: 0001641172-25-009464 Size: 3 MB

New Form 6-K - Altamira Therapeutics Ltd. Filed: 2025-05-09 AccNo: 0001213900-25-041560 Size: 2 MB

Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 144 - COHERENT CORP. Filed: 2025-05-09 AccNo: 0001950047-25-002850 Size: 4 KB